Managing diabetes and COVID-19: A national strategic framework

被引：1
作者：
Mohan, Viswanathan [1 ,2 ]
Ramesh, Jagannathan [3 ]
机构：
[1] Dr Mohans Diabet Special Ctr, 4 Conran Smith Rd, Chennai 600086, Tamil Nadu, India
[2] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India
[3] Indian Soc Clin Res, Bengaluru, Karnataka, India
来源：
INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES | 2020年 / 5卷 / 02期
关键词：
COVID-19; diabetes; higher risk; infection; precautions; PREVALENCE; POPULATION; INDIA;
D O I：
10.4103/jncd.jncd_39_20
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The coronavirus disease (COVID-19) pandemic has been one of the greatest health challenges that humanity has witnessed in recent times. Diabetes mellitus is one of the most common noncommunicable diseases and its prevalence is very high in evlderly people. COVID-19 also has a worse prognosis in elderly people. Hence, most of the data, both nationally and internationally, have shown that people with uncontrolled diabetes have worse outcomes compared to people without diabetes. This article reviews the connection between diabetes and COVID-19 and suggests various precautions to be taken for people with diabetes, the management strategies for diabetes and lays down a strategic framework for managing people with diabetes and COVID-19.
引用
收藏
页码：58 / 62
页数：5
相关论文
共 13 条
  • [1] Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
    不详
    [J]. DIABETES CARE, 2020, 43 : S98 - S110
  • [2] American Diabetes Association, 2021, DIABETES CARE, V44, pS1, DOI DOI 10.2337/dc19-SINT01
  • [3] Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study
    Anjana, Ranjit Mohan
    Deepa, Mohan
    Pradeepa, Rajendra
    Mahanta, Jagadish
    Narain, Kanwar
    Das, Hiranya Kumar
    Adhikari, Prabha
    Rao, Paturi Vishnupriya
    Saboo, Banshi
    Kumar, Ajay
    Bhansali, Anil
    John, Mary
    Luaia, Rosang
    Reang, Taranga
    Ningombam, Somorjit
    Jampa, Lobsang
    Budnah, Richard O.
    Elangovan, Nirmal
    Subashini, Radhakrishnan
    Venkatesan, Ulagamathesan
    Unnikrishnan, Ranjit
    Das, Ashok Kumar
    Madhu, Sri Venkata
    Ali, Mohammed K.
    Pandey, Arvind
    Dhaliwal, Rupinder Singh
    Kaur, Tanvir
    Swaminathan, Soumya
    Mohan, Viswanathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) : 585 - 596
  • [4] Type 2 Diabetes and its Impact on the Immune System
    Berbudi, Afiat
    Rahmadika, Nofri
    Tjahjadi, Adi Imam
    Ruslami, Rovina
    [J]. CURRENT DIABETES REVIEWS, 2020, 16 (05) : 442 - 449
  • [5] Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study
    Carey, Iain M.
    Critchley, Julia A.
    DeWilde, Stephen
    Harris, Tess
    Hosking, Fay J.
    Cook, Derek G.
    [J]. DIABETES CARE, 2018, 41 (03) : 513 - 521
  • [6] Clinical considerations for patients with diabetes in times of COVID-19 epidemic
    Gupta, Ritesh
    Ghosh, Amerta
    Singh, Awadhesh Kumar
    Misra, Anoop
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) : 211 - 212
  • [7] Increase in the Incidence of Diabetes and Its Implications
    Ingelfinger, Julie R.
    Jarcho, John A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) : 1473 - 1474
  • [8] International Diabetes Federation, 2019, IDF Diabetes Atlas, V9th
  • [9] Diabetes in the Elderly
    Kalra, Sanjay
    Sharma, Suresh K.
    [J]. DIABETES THERAPY, 2018, 9 (02) : 493 - 500
  • [10] Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
    Leon, Benjamin M.
    Maddox, Thomas M.
    [J]. WORLD JOURNAL OF DIABETES, 2015, 6 (13) : 1246 - 1258
12